Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatases isoform 3 inhibitor ACT-PFK-158
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ACT-PFK-01, NCI-2014-02632, NCT02044861
Start Over